How many patents does
Acceleron Pharma have?
patents
1,148
families
85
granted
226
applications
922
US
240
EP
146
JP
110
WO
79
CN
78
KR
66
RoW
429
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Acceleron Pharma
Top ten assignees appearing on patents
2009 - 2018
| acceleron pharma | 919 |
| celgene corporation | 20 |
| adimab | 9 |
| dyax corporation | 3 |
| acceleron pharma inc. (us) | 1 |
2009
| acceleron pharma | 61 |
2018
| acceleron pharma | 137 |
| celgene corporation | 8 |
| adimab | 2 |
| dyax corporation | 1 |
Acceleron Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| activin-actriia antagonists and uses for promoting bone growth | 78 | 2005 |
| activin-actrii antagonists and uses for increasing red blood cell levels | 75 | 2006 |
| variants derived from actriib and uses therefor | 73 | 2007 |
| activin-actriia antagonists and uses for promoting bone growth in cancer patients | 51 | 2007 |
| alk7:actriib heteromultimers and uses thereof | 44 | 2015 |
| use of gdf traps to increase red blood cell levels | 38 | 2008 |
| activin-actriia antagonists and uses for treating or preventing breast cancer | 36 | 2007 |
| methods for dosing an activin-actriia antagonist and monitoring of treated patients | 33 | 2008 |
| combined use of gdf traps and erythropoietin receptor activators to increase red blood c… 🛈 | 33 | 2008 |
| alk1 receptor and ligand antagonists and uses thereof | 33 | 2006 |